Transcription of Public Assessment Report Decentralised Procedure - …
{{id}} {{{paragraph}}}
Example: marketing
Public Assessment Report Decentralised Procedure - …
Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC UK Licence No: PL 00289/2116 Teva UK Limited PAR Liothyronine Sodium 20 microgram Tablets UK/H/6516/001/DC 2 LAY SUMMARY Liothyronine Sodium 20 microgram Tablets (liothyronine sodium) This is a summary of the Public Assessment Report (PAR) for Liothyronine Sodium 20 microgram Tablets (PL 00289/2116; UK/H/6516/001/DC). It explains how Liothyronine Sodium 20 microgram Tablets were assessed and their authorisation recommended as well as their conditions of use.
PAR Liothyronine Sodium 20 microgram Tablets UK/H/6516/001/DC 3 What benefits of Liothyronine Sodium Tablets have been shown in studies? As Liothyronine Sodium Tablets are a generic medicine, studies in people have been limited to tests to
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: